Feature

CAR T-cell therapy turns 10 and finally earns the word ‘cure’

Publish date: July 22, 2022

 

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

‘Highly encouraging’ MRD results for zanubrutinib add-on in CLL
B-Cell Lymphoma ICYMI
DKMS: Small nonprofit to world’s largest stem cell donor registry
B-Cell Lymphoma ICYMI
Rituximab and COVID-19 vaccines: Studies begin to answer key questions
B-Cell Lymphoma ICYMI
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'
B-Cell Lymphoma ICYMI
CLL patients ‘cured’: 10 years post infusion, CAR T cells persist
B-Cell Lymphoma ICYMI
Stopping venetoclax treatment early reduces CLL survival outcomes
B-Cell Lymphoma ICYMI
Eating olive oil may slow CLL disease progression
B-Cell Lymphoma ICYMI
First-line CAR T-cell therapy could help cure some lymphomas
B-Cell Lymphoma ICYMI
Some leukemias detectable up to 16 years before diagnosis?
B-Cell Lymphoma ICYMI
FDA warning: Lymphoma drug heightens risk of death
B-Cell Lymphoma ICYMI